Risk factors
Glucotrack (GCTK) risk factors
Item 1A of every Glucotrack, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors35 risks3 new1 dropped8 reworded
The company abandoned its first-generation international product and CE Mark, pivoting focus to the new Glucotrack CBGM product under preclinical development in the U.S.
Filed Mar 30, 2026 - FY2024 10-K risk factors33 risks
The company relies heavily on the success of its flagship medical device, Glucotrack CBGM, which is not yet approved.
Filed Mar 31, 2025